Acta Pediátrica de México

Contents by Year, Volume and Issue

Table of Contents

General Information

Instructions for Authors

Message to Editor

Editorial Board

>Journals >Acta Pediátrica de México >Year 2015, Issue 4

Garrido-García LM, Soto-Blanquel JL, Espinosa-Rosales FJ
Kawasaki disease: clinical features, laboratory and coronary artery lesions
Acta Pediatr Mex 2015; 36 (4)

Language: Español
References: 17
Page: 314-321
PDF: 698.59 Kb.

Full text


Kawasaki disease (KD) is a systemic acute vasculitis of unknown etiology that mainly (80%) affects patients under 5 years of age. KD presents with fever, bilateral non-purulent conjunctivitis, oral mucosa changes, cervical adenopathy, cutaneous changes in extremities and unspecific exanthema. Opportune diagnosis of KD is a challenge for clinicians, mainly because there are no specific tests, and clinical criteria originally described in 1967 are still valid. Laboratory changes in the acute phase of the disease are not specific nor diagnostic.
Objectives: To describe the clinical features, laboratory findings, treatment employed and development of coronary artery aneurysms in the acute phase of patients with Kawasaki Disease (KD) treated in a tertiary care children’s hospital in Mexico City.
Methods: Retrospective and observational study in patients with diagnosis of Kawasaki Disease treated from August 1995 to December 2013. Information gathered included patient demographics, clinical features, laboratory results, treatment and echocardiographic findings in the acute phase of the disease.
Results: We studied 338 cases of KD in 322 patients. Mean age at diagnosis was 38.94 ± 36.53 months, (range from 2 to 200 months). 66.9% of our patients were male with a male/female ratio of 2:1. Complete KD was diagnosed in 82.2% of our cases. 298 of the cases received intravenous immunoglobulin (IVIG). In 287 cases the fever resolved after 48 hours of administration of IVIG and only 12 cases required a second dose of IVIG. In the 1995 to 2003 period KD was diagnosed in 48 patients and 22 cases developed coronary artery lesions (45.8%), from 2004 to 2008 KD was diagnosed in 108 patients and 61 cases presented with coronary artery aneurysms (56.5%) and finally, in the 2009 to 2013 period, 182 cases of KD were diagnosed and 52 cases developed coronary artery aneurysms (28.61%). In the overall series, 4 patients died from cardiac complications in the acute phase of the disease.
Conclusion: Diagnosis of KD is becoming more frequent and with an early recognition and prompt treatment, the development of coronary artery aneurysms is diminished.

Key words: Kawasaki Disease, Coronary Artery Aneurysms.


  1. Newburger JW, Takahashi M, Gerber MA, et al. Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease; Council on Cardiovascular Disease in the Young; American Heart Association; American Academy of Pediatrics. Diagnosis, treatment, and long-term management of Kawasaki disease. Circulation. 2004;110: 2747-2771.

  2. Scuccimarri R. Kawasaki Disease. PedClin N Am 2012;59:425-445.

  3. Son MB, Newburger J. Kawasaki Disease. Pediatr Rev 2013;34:151-162.

  4. Rowley AH, Shulman ST. Recent Advances in the Understanding and Management of Kawasaki Disease. Curr Infect Dis Rep 2010;12:96-102.

  5. Gil-Veloz M, Flores-Ruiz EM, Beirana-Palencia LG, Miranda-Novales MG, Huerta-García GC, Solórzano-Santos F. Enfermedad de Kawasaki: comportamiento clínico y complicaciones cardiovasculares en niños atendidos en un hospital de tercer nivel. Arch Cardiol Mex 2009;79:11-17.

  6. Dallaire F, Dahdah N. New Equations and a Critical Appraisal of Coronary Artery Z Scores in Healthy Children. J Am SocEchocardiogr 2011;24:607-614.

  7. Makino N, Nakamura Y, Yashiro M, Ae R, Tsuboi S, Aoyama Y, Kojo T, Uehara R, Kotoni K, Ynagawa H. Descriptive Epidemiology of Kawasaki Disease in Japan, 2011-2012: From the Results of the 22nd Nationwide Survey. J Epidemiol 2015. Advance Publication by J-Stage doi:10.2188/jea. JE20140089.

  8. Uehara R, Belay ED. Epidemiology of Kawasaki Disease in Asia, Europe and the United States. J Epidemiol 2012;22:79-85.

  9. Rodríguez RS. Síndrome Linfo-Nodo-Muco cutáneo. Reporte de un caso. Bol Med Hosp Infant Mex 1977;34:53-7.

  10. Morales-Quispe J, Espinola-Zavaleta N, Caballero-Caballero R, García-López JJ, Rodríguez-Quezada JM, Betanzos-Rodríguez L. Enfermedad de Kawasaki: evolución y complicaciones cardiovasculares en Niños. Rev Med InstMexSeguroSoc 2011;49-295-300.

  11. Soto-Amador K, Saltigral-Simental P, Fernández-Gaytán G. Enfermedad de Kawasaki. Prevalencia en el Hospital Infantil Privado. Rev EnfInfecPediatr 2011;24:109-113.

  12. Sotelo-Cruz N. Revisión de la Enfermedad de Kawasaki en México, desde la perspectiva de las publicaciones médicas (Enero de 1977 a Mayo de 2012). Arch CardiolMex 2013;83:214-222.

  13. Rodríguez-Herrera R, Carbajal-Rodríguez L, Reynés-Manzur JN, García-Piña CA, Barrios-Fuentes R, Zarco-Román J, Belmont-Martínez L, Flores-Díaz JL. Enfermedad de Kawasaki. Experiencia Mexicana. ActaPediatrMex 2001;22:97-103

  14. Kim JJ, Hong YM, Yun SW, Han MK, Lee KY et al. Assessment of Risk Factors for Korean Children with Kawasaki Disease. PediatrCardiol 2012;33:413-520.

  15. González-Mata A, Ulloa-Gutiérrez R, Brea del Castillo J, Soza G,Tremoulet AH. Orígenes e importancia de la Red de Enfermedad de Kawasaki en América Latina (REKAMLATINA). Rev ChilenaInfectol 2013;30:402-404.

  16. Ulloa-Gutiérrez R, Salgado A, Estripeaut D, et al. Multicenter Retrospective Study of the Clinical Course of Kawasaki Disease in Latin American Children. 11th International Kawasaki Disease Symposium. Honolulu, Hawaii, USA. February 3rd, 2015.

  17. Huang SK, Lin MT, Chen HC, Chung-Huang SC, Wu MH. Epidemiology of Kawasaki Disease: Prevalence from National Database and Future Trends Projection by System Dynamics Modeling J Pediatr 2013;63:126-131.

>Journals >Acta Pediátrica de México >Year 2015, Issue 4

· Journal Index 
· Links 

Copyright 2019